Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0037116 (silicosis)
 1,822 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Exposure to silica dust can result in lung inflammation that may progress to fibrosis, for which there is no effective clinical treatment. The mechanisms involved in the development of pulmonary silicosis have not been well defined; however, most current evidence implicates a central role for alveolar macrophages (AM) in this process. We propose that the fibrotic potential of a particulate depends upon its ability to cause apoptosis in AM. In this study, human AM were treated with fibrogenic, poorly fibrogenic, and nonfibrogenic model particulates, such as silica (133 micrograms/ml), amorphous silica (80 micrograms/ml), and titanium dioxide (60 micrograms/ml), respectively. Cell were treated with these particulates in vitro for 6 and 24 hr and examined for apoptosis by morphological analysis, DNA fragmentation, and levels of cytosolic histone-bound DNA fragments (cell death ELISA assays). Treatment with silica resulted in morphological changes typical of apoptotic cells, enhanced DNA fragmentation (a characteristic feature of programmed cell death), and significant alveolar macrophage apoptosis as observed by cell death ELISA assays. In contrast, amorphous silica and titanium dioxide demonstrated no significant apoptotic potential. To elucidate the possible mechanism by which silica causes apoptosis, we investigated the role of the scavenger receptor (SR) in silica-induced apoptosis. Cells were pretreated with and without SR ligand binding inhibitor, polyinosinic acid (poly(I), 500 micrograms/ml), for 10 min prior to silica treatment. Pretreatment with poly(I) resulted in complete inhibition of silica-induced apoptosis as measured by cell death ELISA. Further, we examined the involvement of interleukin-converting enzyme (ICE) in silica-mediated apoptosis using an ICE inhibitor, Z-Val-Ala-Asp-fluoromethyl ketone. Z-Val-Ala-Asp-fluoromethyl ketone inhibited silica-induced apoptosis and IL-1 beta release. These results suggest that fibrogenic particulates, such as silica, caused apoptosis of alveolar macrophages and that this apoptotic potential of fibrogenic particulates may be a critical factor in initiating an inflammatory response resulting in fibrosis. Additionally, silica-induced apoptosis of alveolar macrophages may be due to the interaction of silica particulates with the SR, initiating one or a number of signaling pathways involving ICE, ultimately leading to apoptosis.
 ...
PMID:Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages. 891 79

Immune-mediated pulmonary diseases are a group of diseases that resulted from immune imbalance initiated by allergens or of unknown causes. Inflammatory responses without restrictions cause tissue damage and remodeling, which leads to airway hyperactivity, destruction of alveolar architecture, and a resultant loss of lung function. Epigenetic mechanisms have been demonstrated to be involved in inflammation, autoimmunity, and cancer. Recent studies have identified that epigenetic changes also regulate molecular pathways in immune-mediated lung diseases. Aberrant DNA methylation status, dysregulation of histone modifications, as well as altered microRNAs expression could change transcription activity of genes involved in the development of immune-mediated pulmonary diseases, which contributes to skewed differentiation of T cells and proliferation and activation of myofibroblasts, leading to overproduction of inflammatory cytokines and excessive accumulation of extracellular matrix, respectively. Aside from this, epigenetics also explains how environmental exposure influence on gene transcription without genetic changes. It acts as a mediator of the interaction between environmental factors and genetic factors. Identification of the abnormal epigenetic marks in diseases provides novel biomarkers for prediction and diagnosis and affords novel therapeutic targets for those difficult clinical problems, such as steroid-resistance and rapidly progressing fibrosis. In this review, we summarized the latest experimental and translational epigenetic studies in immune-mediated pulmonary diseases, including asthma, idiopathic pulmonary fibrosis, tuberculosis, sarcoidosis, and silicosis.
...
PMID:Epigenetics in immune-mediated pulmonary diseases. 2424 59